All Stories

  1. The Radioprotective Potentials of Silymarin/Silibinin Against Radiotherapy- Induced Toxicities: A Systematic Review of Clinical and Experimental Studies
  2. Stem cell-derived exosomes in bone healing: focusing on their role in angiogenesis
  3. Oncogenic Viruses-Encoded microRNAs and Their Role in the Progression of Cancer: Emerging Targets for Antiviral and Anticancer Therapies
  4. Seroprevalence and Risk Factors for Toxoplasma gondii Infection in Horses
  5. Engineering and surface modification of carbon quantum dots for cancer bioimaging
  6. Synthesis, biological evaluation and molecular docking study of some new 4-aminosalicylic acid derivatives as anti-inflammatory and antimycobacterial agents
  7. Genome-Wide Identification of B3 DNA-Binding Superfamily Members (ABI, HIS, ARF, RVL, REM) and Their Involvement in Stress Responses and Development in Camelina sativa
  8. M-Mode Echocardiographic Measurements of Interventricular Septum, Left Ventricular Internal Diameter, and Left Ventricular Free-Wall Thickness in Normal Horses—A Meta-Analytical Study
  9. Synergistic Impact of Melatonin and Putrescine Interaction in Mitigating Salinity Stress in Snap Bean Seedlings: Reduction of Oxidative Damage and Inhibition of Polyamine Catabolism
  10. The Interaction of Programmed Cell Death Protein and Its Ligands with Non-Coding RNAs in Neoplasms: Emerging Anticancer Immunotherapeutics
  11. The Safety and Efficacy of the Protease Inhibitors Lopinavir/Ritonavir as Monotherapy or Combined with Interferon in COVID-19 Patients
  12. Implications of biomimetic nanocarriers in targeted drug delivery
  13. A randomized crossover study of the effect of butorphanol–lidocaine and tramadol–lidocaine on sevoflurane's minimum alveolar concentration in dogs
  14. Comparing the anti‐nociceptive, sedative and clinicophysiological effects of epidural detomidine, detomidine–lidocaine and lidocaine in donkeys
  15. Comparative evaluation of sedative and anti-nociceptive effects of epidural romifidine, romifidine–lidocaine, and lidocaine in donkeys (Equus asinus)
  16. Meta-analysis of seroprevalence and zoonotic infections of Middle East respiratory syndrome coronavirus (MERS-CoV): A one-health perspective
  17. Recent progress in synthesis and applications of MXene-based nanomaterials (MBNs) for (bio)sensing of microbial toxins, pathogenic bacteria in food matrices
  18. Novel Copper Oxide Bio-Nanocrystals to Target Outer Membrane Lectin of Vancomycin-Resistant Enterococcus faecium (VREfm): In Silico, Bioavailability, Antimicrobial, and Anticancer Potential
  19. SRF / MRTF‐A and liver cirrhosis: Pathologic associations
  20. Carnosine Potentiates Doxorubicin-Induced Cytotoxicity in Resistant NCI/ADR-RES Cells by Inhibiting P-Glycoprotein—In Silico and In Vitro Evidence
  21. The Broad-Spectrum Antitrypanosomal Inhibitory Efficiency of the Antimetabolite/Anticancer Drug Raltitrexed
  22. Paeonol Protects against Methotrexate Hepatotoxicity by Repressing Oxidative Stress, Inflammation, and Apoptosis—The Role of Drug Efflux Transporters
  23. Computational Design, Synthesis, and Pharmacological Evaluation of Naproxen-Guaiacol Chimera for Gastro-Sparing Anti-Inflammatory Response by Selective COX2 Inhibition
  24. Functional Role of Novel Anthranilic Acid Derivatives as Anti-inflammatory Agents
  25. The synergistic effects of the probiotic ( Lactobacillus fermentum ) and cinnamon, Cinnamomum sp. powder on growth performance, intestinal microbiota, immunity, antioxidant defence and resis...
  26. Structure-Activity Relationship of Anionic and Cationic Polyamidoamine (PAMAM) Dendrimers against Staphylococcus aureus
  27. Risk-associated factors associated with the bovine viral diarrhea virus in dromedary camels, sheep, and goats in abattoir surveillance and semi-closed herd system
  28. Camel viral diseases: Current diagnostic, therapeutic, and preventive strategies
  29. Aqueous Ginger (Zingiber officinale) Extract Ameliorates the Harmful Effects of High-Dose Lornoxicam in Albino Male Rats
  30. Fabrication and Characterization of a Novel and Efficient Zinc Nanomagnetic Catalyst for Multicomponent Synthesis of Heterocycles
  31. Applications of Natural Violet Pigments from Halophilic Chromobacterium violaceum PDF23 for Textile Dyeing with Antimicrobial and Antioxidant Potentials
  32. Smartphone-Based Techniques Using Carbon Dot Nanomaterials for Food Safety Analysis
  33. Camel Proteins and Enzymes: A Growing Resource for Functional Evolution and Environmental Adaptation
  34. Targeting Streptomyces-Derived Streptenol Derivatives against Gynecological Cancer Target PIK3CA: An In Silico Approach
  35. The Outcomes of Sodium-Glucose Co-transporter 2 Inhibitors (SGLT2I) on Diabetes-Associated Neuropathy: A Systematic Review and meta-Analysis
  36. Omicron variant receptor-binding domain phylogenetics and molecular dynamics
  37. The effect of type and size of nanoparticles and porosity on the pool boiling heat transfer of water/Fe nanofluid: Molecular dynamics approach
  38. Fabrication of Silver Nanoparticles Using Fimbristylis miliacea: A Cheap and Effective Tool against Invasive Mosquito Vector, Aedes albopictus
  39. Acaricidal Potential and Ecotoxicity of Metallic Nano-Pesticides Used against the Major Life Stages of Hyalomma Ticks
  40. Comparative Study of the Sedative and Anti-nociceptive Effects of Sacrococcygeal Epidural Administration of Romifidine, Lidocaine, and Romifidine/Lidocaine in the Dromedary Camel
  41. Antitubercular, Cytotoxicity, and Computational Target Validation of Dihydroquinazolinone Derivatives
  42. Ameliorative Effect of a Neoteric Regimen of Catechin plus Cetirizine on Ovalbumin-Induced Allergic Rhinitis in Rats
  43. The Application of Natural Camel Milk Products to Treat Autism-Spectrum Disorders: Risk Assessment and Meta-Analysis of Randomized Clinical Trials
  44. Abiraterone Acetate Attenuates SARS-CoV-2 Replication by Interfering with the Structural Nucleocapsid Protein
  45. 1,2,3-Triazolyl-tetrahydropyrimidine Conjugates as Potential Sterol Carrier Protein-2 Inhibitors: Larvicidal Activity against the Malaria Vector Anopheles arabiensis and In Silico Molecular Docking Study
  46. The Protective Effect of Anethole against Renal Ischemia/Reperfusion: The Role of the TLR2,4/MYD88/NFκB Pathway
  47. Drug Discovery of New Anti-Inflammatory Compounds by Targeting Cyclooxygenases
  48. Novel Natural Surfactant-Based Fatty Acids and Their Corrosion-Inhibitive Characteristics for Carbon Steel-Induced Sweet Corrosion: Detailed Practical and Computational Explorations
  49. Antiviral drug discovery by targeting the SARS-CoV-2 polyprotein processing by inhibition of the main protease
  50. Paeonol Protects Against Methotrexate-Induced Nephrotoxicity via Upregulation of P-gp Expression and Inhibition of TLR4/NF-κB Pathway
  51. Effect of Azospirillum and Azotobacter Species on the Performance of Cherry Tomato under Different Salinity Levels
  52. Omicron variant genome evolution and phylogenetics
  53. PHARMACOKINETICS OF THE LONG-ACTING CEFTIOFUR CRYSTALLINE-FREE ACID IN ARABIAN SHE-CAMELS (Camelus dromedarius)
  54. Bioinformatics of thymidine metabolism in Trypanosoma evansi: exploring nucleoside deoxyribosyltransferase (NDRT) as a drug target
  55. Pharmacokinetic, Clinical, and Myeloid Marker Responses to Acepromazine Sedation in Arabian Camels
  56. Immunomodulatory Effects of the Cyclooxygenase Inhibitor Lornoxicam on Phenotype and Function of Camel Blood Leukocytes
  57. Crystallography, Molecular Modeling, and COX-2 Inhibition Studies on Indolizine Derivatives
  58. Discovery of New Potent anti-MERS CoV Fusion Inhibitors
  59. Recent Advances on the Bovine Viral Diarrhea Virus Molecular Pathogenesis, Immune Response, and Vaccines Development
  60. Discovery of New Fusion Inhibitor Peptides against SARS-CoV-2 by Targeting the Spike S2 Subunit
  61. Mycophenolate suppresses inflammation by inhibiting prostaglandin synthases: a study of molecular and experimental drug repurposing
  62. 4-Aryl-1,4-Dihydropyridines as Potential Enoyl-Acyl Carrier Protein Reductase Inhibitors: Antitubercular Activity and Molecular Docking Study
  63. Clinical Efficacy of Antimicrobial Agents in Combination with Flunixin Meglumine and Phenylbutazone on Acute Phase Response in Respiratory Disease of Calves
  64. Characterization of the 5′-flanking region of the human and mouse CHAC1 genes
  65. Sulfonamide antibiotics inhibit RNAi by binding to human Argonaute protein 2 PAZ
  66. Repurposing FDA-approved phytomedicines, natural products, antivirals and cell protectives against SARS-CoV-2 (COVID-19) RNA-dependent RNA polymerase
  67. Anti-proliferative activity of leaves of Launaea capitata Asteraceae: Phytochemical, cytotoxicity and in silico studies
  68. Investigation of acute-phase proteins and cytokines response in goats with contagious caprine pleuropneumonia with special reference to their diagnostic accuracy
  69. Antibody-Based Immunotherapeutic Strategies for COVID-19
  70. The emerging SARS‐CoV‐2 papain‐like protease: Its relationship with recent coronavirus epidemics
  71. Metabolic drug targets of the cytosine metabolism pathways in the dromedary camel (Camelus dromedarius) and blood parasite Trypanosoma evansi
  72. Anti-Tubercular Properties of 4-Amino-5-(4-Fluoro-3- Phenoxyphenyl)-4H-1,2,4-Triazole-3-Thiol and Its Schiff Bases: Computational Input and Molecular Dynamics
  73. Small Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Fusion by Targeting Cavities on Heptad Repeat Trimers
  74. Repurposing of FDA-approved antivirals, antibiotics, anthelmintics, antioxidants, and cell protectives against SARS-CoV-2 papain-like protease
  75. Crystallography, in Silico Studies, and In Vitro Antifungal Studies of 2,4,5 Trisubstituted 1,2,3-Triazole Analogues
  76. Study on Genotyping Polymorphism and Sequencing of N-Acetyltransferase 2 (NAT2) among Al-Ahsa Population
  77. In silico and in vitro identification of secoisolariciresinol as a re-sensitizer of P-glycoprotein-dependent doxorubicin-resistance NCI/ADR-RES cancer cells
  78. Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease
  79. A pilot study of the antiviral activity of anionic and cationic polyamidoamine dendrimers against the Middle East respiratory syndrome coronavirus
  80. Cytotoxicity and Antimycobacterial Properties of Pyrrolo[1,2-a]quinoline Derivatives: Molecular Target Identification and Molecular Docking Studies
  81. Screening and Molecular Docking of Novel Benzothiazole Derivatives as Potential Antimicrobial Agents
  82. A pilot study on the pharmacokinetics of a single intramuscular injection of cefquinome in Arabian camel calves
  83. From SARS and MERS CoVs to SARS‐CoV‐2: Moving toward more biased codon usage in viral structural and nonstructural genes
  84. Analysis of preferred codon usage in the coronavirus N genes and their implications for genome evolution and vaccine design
  85. Isolation and characterization of vaginal Lactobacillus spp. in dromedary camels (Camelus dromedarius): in vitro evaluation of probiotic potential of selected isolates
  86. Bioinformatics of Thymidine metabolism in camels and Trypanosoma evansi: nucleoside deoxyribosyltransferase (NDRT) as a drug target
  87. Bioinformatics of pyrimidine metabolism in camels and Trypanosoma evansi: Uridine 5'-Diphosphate (UDP) Metabolic pathways and targeting atp diphosphatase
  88. Bioinformatics of uridine/deoxyuridine paths in Trypanosoma evansi revealed targeting uridine phosphorylase and cytidine deaminase
  89. Deoxyuridine 5-Monophosphate (dUMP) metabolising enzyme and the bifunctional dihydrofolate reductase-thymidylate synthase in camels and Trypanosoma evansi
  90. Dexamethasone as a Treatment of COVID-19
  91. Molecular dynamics simulation of carbonyl reductase 1 clarifies the structural switch in drug metabolism
  92. Uridine 5’-monophosphate (UMP) metabolising enzymes uracil phosphoribosyltransferase and orotidine-5’-phosphate decarboxylase/ump synthase in camels and Trypanosoma evansi
  93. Uridine 5-triphosphate (UTP) metabolising enzymes nucleoside diphosphate kinase and cytidine triphosphate (CTP) synthase in camels and Trypanosoma evansi
  94. Characterization of IRE1α in Neuro2a cells by pharmacological and CRISPR/Cas9 approaches
  95. Cefotaxime pharmacokinetics in Arabian camel (Camelus dromedarius) calves after single intravenous injection
  96. Molecular Dynamics and Inhibition of MERS CoV Papain-like Protease by Small Molecule Imidazole and Aminopurine Derivatives
  97. Synthesis and Structural Elucidation of Novel Benzothiazole Derivatives as Anti-tubercular Agents: In-silico Screening for Possible Target Identification
  98. Gene expression of multidrug-resistant ATP-binding cassette transporter (MDR1/ABCB1) in bovine mastitis
  99. The structural basis of unique substrate recognition by Plasmodium thymidylate kinase: Molecular dynamics simulation and inhibitory studies
  100. Species specificity and host affinity rather than tissue tropism controls codon usage pattern in respiratory mycoplasmosis
  101. Methicillin resistant Staphylococcus aureus among goat farms in Eastern province, Saudi Arabia: Prevalence and risk factors
  102. Molecular dynamics of Middle East Respiratory Syndrome Coronavirus (MERS CoV) fusion heptad repeat trimers
  103. Molecular dynamics and binding selectivity of nucleotides and polynucleotide substrates with EIF2C2/Ago2 PAZ domain
  104. Flavonoid and Phenolic Compounds from Carissa macrocarpa: Molecular Docking and Cytotoxicity Studies
  105. Comparative Genomic Analysis MERS CoV Isolated from Humans and Camels with Special Reference to Virus Encoded Helicase
  106. Middle east respiratory syndrome coronavirus in healthy and diseased dromedaries
  107. Molecular Dynamic Studies of Interferon and Innate Immunity Resistance in MERS CoV Non-Structural Protein 3
  108. Synonymous and Biased Codon Usage by MERS CoV Papain-Like and 3CL-Proteases
  109. Evolution of camel CYP2E1 and its associated power of binding toxic industrial chemicals and drugs
  110. Annotation of Camel Genome for Estimation of Drug Binding Power, Evolution and Adaption of Cytochrome P450 1a2
  111. Molecular analysis of some camel cytochrome P450 enzymes reveals lower evolution and drug-binding properties
  112. Pharmacokinetics and oral bioavailability of amoxicillin in chicken infected with caecal coccidiosis
  113. Synthesis of non-prenyl analogues of baccharin as selective and potent inhibitors for aldo-keto reductase 1C3
  114. Bioavailability and Pharmacokinetics of Ampicillin in Chicken Infected with Eimeria tenella
  115. Cleavage of DNA and Nuclease Properties of Plasmodium Nucleoside Diphosphate Kinase
  116. Bioenergetics and Gene Silencing Approaches for Unraveling Nucleotide Recognition by the Human EIF2C2/Ago2 PAZ Domain
  117. Association of host tropism of Middle East syndrome coronavirus with the amino acid structure of host cell receptor dipeptidyl peptidase 4
  118. Synthesis of carbocyclic pyrimidine nucleosides and their inhibitory activities against Plasmodium falciparum thymidylate kinase
  119. Molecular dynamics and energetic perceptions of substrate recognition by thymidylate kinase
  120. In silico molecular docking analysis of the human Argonaute 2 PAZ domain reveals insights into RNA interference
  121. Computational Analysis of siRNA Recognition by the Ago2 PAZ Domain and Identification of the Determinants of RNA-Induced Gene Silencing
  122. Current and future asthma therapies
  123. Carbocyclic thymidine derivatives efficiently inhibit Plasmodium falciparum thymidylate kinase (PfTMK)
  124. Thermodynamics and molecular bases of the interaction of ampicillin and streptomycin at their binding sites of bovine serum albumin
  125. Synthesis and biological properties of chemically modified siRNAs bearing 1-deoxy-d-ribofuranose in their 3′-overhang region
  126. Macromolecular interactions of spectinomycin with Bovine serum albumin
  127. Analysis of the molecular interactions and complexation of chloroquine with bovine serum albumin
  128. The binding interactions of the macrolide endectocide ivermectin with the antibiotics ampicillin, chloramphenicol and tetracycline HCL
  129. The Protective Effects of Nigella sativa Oil and Allium sativum Extract on Amikacin-induced Nephrotoxicity
  130. Nephrotoxicity and Oxidative Stress of Single Large Dose or Two Divided Doses of Gentamicin in Rats
  131. The Substrate Binding Preferences of Plasmodium Thymidylate Kinase
  132. Binding dynamics and energetic insight into the molecular forces driving nucleotide binding by guanylate kinase
  133. Substrate specificity and nucleotides binding properties of NM23H2/nucleoside diphosphate kinase homolog from Plasmodium falciparum
  134. Bioinformatics, Enzymologic Properties, and Comprehensive Tracking of Plasmodium falciparum Nucleoside Diphosphate Kinase
  135. Mutational, inhibitory and microcalorimetric analyses of Plasmodium falciparum TMP kinase. Implications for drug discovery
  136. Molecular cloning, expression, characterization and mutation of Plasmodium falciparum guanylate kinase
  137. Molecular Characterization, Heterologous Expression and Kinetic Analysis of Recombinant Plasmodium falciparum Thymidylate Kinase
  138. Facile synthesis of 1′,2′-cis-β-pyranosyladenine nucleosides